Aim Equities

AIM ImmunoTech Reveals New Segment in CEO Corner Featuring Insights from CEO Thomas Equels Jul 30, 2024

AIM ImmunoTech Announces Q3 2023 Financial Results and Updates on Ampligen's Clinical Advancements Nov 16, 2023